Call to arrange a consultation
+1 416 777 0888

Merck Sharp & Dohme Corp. et al. v. Dr. Reddy’s Laboratories Ltd.

2021
T-249-21; T-250-21; T-251-21; T-252-21
Resolved
Patent Infringement

Actions under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,450,740, No. 2,529,400 and No. 2,536,251 as well as  patent infringement actions relating to Patent No. 2,518,435 with respect to products containing sitagliptin and products containing both sitagliptin and metformin.

Counsel to: 
Dr. Reddy’s Laboratories Ltd.
here.

Meet the team

Arrow down